İlhan, N.; Doğan, A.; Erölmez, H.N.; Atalah, F.; Baş, S.; Yasar, S.; Odabaş, H.; Gümüş, M.
The Incidence and Clinical Characteristics of Interstitial Lung Disease Associated with CDK4/6 Inhibitors in Breast Cancer Patients: A Retrospective Multicenter Study. Medicina 2025, 61, 549.
https://doi.org/10.3390/medicina61030549
AMA Style
İlhan N, Doğan A, Erölmez HN, Atalah F, Baş S, Yasar S, Odabaş H, Gümüş M.
The Incidence and Clinical Characteristics of Interstitial Lung Disease Associated with CDK4/6 Inhibitors in Breast Cancer Patients: A Retrospective Multicenter Study. Medicina. 2025; 61(3):549.
https://doi.org/10.3390/medicina61030549
Chicago/Turabian Style
İlhan, Nurullah, Akif Doğan, Hande Nur Erölmez, Fatih Atalah, Süleyman Baş, Servan Yasar, Hatice Odabaş, and Mahmut Gümüş.
2025. "The Incidence and Clinical Characteristics of Interstitial Lung Disease Associated with CDK4/6 Inhibitors in Breast Cancer Patients: A Retrospective Multicenter Study" Medicina 61, no. 3: 549.
https://doi.org/10.3390/medicina61030549
APA Style
İlhan, N., Doğan, A., Erölmez, H. N., Atalah, F., Baş, S., Yasar, S., Odabaş, H., & Gümüş, M.
(2025). The Incidence and Clinical Characteristics of Interstitial Lung Disease Associated with CDK4/6 Inhibitors in Breast Cancer Patients: A Retrospective Multicenter Study. Medicina, 61(3), 549.
https://doi.org/10.3390/medicina61030549
